Short Interest in Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Expands By 225.0%

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 1,300 shares, a growth of 225.0% from the August 31st total of 400 shares. Based on an average trading volume of 4,700 shares, the short-interest ratio is currently 0.3 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Up 0.1 %

NASDAQ HROWM traded up $0.04 during trading on Thursday, hitting $26.80. 3,361 shares of the company’s stock were exchanged, compared to its average volume of 4,219. The stock’s 50 day moving average price is $26.28 and its two-hundred day moving average price is $26.35. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a fifty-two week low of $22.71 and a fifty-two week high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 31st. Shareholders of record on Monday, July 15th were issued a $0.7422 dividend. The ex-dividend date of this dividend was Monday, July 15th. This represents a $2.97 dividend on an annualized basis and a yield of 11.08%.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.